Appetite News and Research

RSS

Health Canada monitors recall of Jetfuel Superburn containing undeclared drug substances

"Jetfuel Superburn" is being recalled after Health Canada tests confirmed it contains two undeclared amphetamine-like drug substances that pose serious health risks (beta-methylphenethylamine and phenylpropylmethylamine).

25 Dec 2014

Eating habits and brain chemistry: an interview with Dr Kevin Hall

Several times every day, we choose when, where, what, with whom, and how much to eat. Many of these eating decisions have become automatic and don’t require cognitive effort.

22 Dec 2014

People need to watch distinct warning signs of holiday depression

While the holidays are a time of merriment and festivities for many, some people struggle with depression during this time of year.

14 Dec 2014

GHC, DSM highlight the growing issue of micronutrient deficiency in the U.S.

Global Health Corps and DSM called attention to the growing issue of micronutrient deficiency in the U.S. in a press conference with Barbara Bush, CEO of GHC, Hugh Welsh, President of DSM North America, Newark Municipal Council President Mildred Crump and Jim White, Executive Director of Covenant House New Jersey.

14 Dec 2014

Figitumumab development discontinued for non-adenocarcinoma NSCLC

Adding the novel insulin-like growth factor 1 receptor inhibitor figitumumab to the epidermal growth factor receptor–tyrosine kinase inhibitor erlotinib does not improve survival in patients with non-adenocarcinoma non-small-cell lung carcinoma, research shows.

12 Dec 2014

Scientists identify brain mechanism that drives our appetite for glucose-rich foods

Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.

10 Dec 2014

Triple hormone reduces body weight, improves insulin sensitivity

Recently, the researchers had constructed several single molecules with dual hormone action. Now, for the first time, the researchers succeeded in designing a substance that combines three metabolically active hormone components (GLP-1, GIP and glucagon) and offers unmatched potency to fight metabolic diseases in pre-clinical trials.

9 Dec 2014

McMaster University researchers identify hormone that contributes to obesity, diabetes

Researchers from McMaster University have identified an important hormone that is elevated in obese people and contributes to obesity and diabetes by inhibiting brown fat activity.

8 Dec 2014

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Amgen today announced that the U.S. Food and Drug Administration has approved a new indication for XGEVA (denosumab) for the treatment of hypercalcemia of malignancy (HCM) refractory to bisphosphonate therapy.

8 Dec 2014

Growth genes seem different in Hunger Winter children

Individuals conceived in the severe Dutch Famine, also called the Hunger Winter, may have adjusted to this horrendous period of World War II by making adaptations to how active their DNA is. Genes involved in growth and development were differentially regulated, according to researchers at the Leiden University Medical Center, Harvard University, and Columbia University's Mailman School of Public Health.

5 Dec 2014

Hormone leptin increases blood pressure that occurs with weight gain

Leptin, a hormone that regulates the amount of fat stored in the body, also drives the increase in blood pressure that occurs with weight gain, according to researchers from Monash University and the University of Cambridge.

5 Dec 2014

BeyondSpring Pharmaceuticals plans to initiate Plinabulin Phase 3 pivotal trial in NSCLC patients

BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it plans to initiate a Phase 3 pivotal trial of lead product candidate, Plinabulin, in patients with non-small cell lung cancer (NSCLC) in the first quarter of 2015.

4 Dec 2014

Pregnant women lacking vitamin E nearly twice as likely to have miscarriage

Pregnant women in Bangladesh with low levels of the most common form of vitamin E are nearly twice as likely to have a miscarriage than those with adequate levels of the vitamin in their blood, according to new research led by the Johns Hopkins Bloomberg School of Public Health.

3 Dec 2014

Appetite News and Research

Health Canada monitors recall of Jetfuel Superburn containing undeclared drug substances

Eating habits and brain chemistry: an interview with Dr Kevin Hall

People need to watch distinct warning signs of holiday depression

GHC, DSM highlight the growing issue of micronutrient deficiency in the U.S.

Figitumumab development discontinued for non-adenocarcinoma NSCLC

Scientists identify brain mechanism that drives our appetite for glucose-rich foods

Triple hormone reduces body weight, improves insulin sensitivity

McMaster University researchers identify hormone that contributes to obesity, diabetes

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Growth genes seem different in Hunger Winter children

Hormone leptin increases blood pressure that occurs with weight gain

BeyondSpring Pharmaceuticals plans to initiate Plinabulin Phase 3 pivotal trial in NSCLC patients

Pregnant women lacking vitamin E nearly twice as likely to have miscarriage

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Runners, walkers come together to participate in 3rd annual Thanksgiving Day 5K

UT Arlington researcher receives grant to educate Hispanic patients about depression, treatment options

Scientists make breakthrough in developing new treatment for advanced bladder cancer

Researchers find that yellow fever mosquitoes contain odor-detecting gene

Asthma patients using behavioral therapy can improve lung health over the long-term

Study measures effects of high-fat maternal diet on the cognitive functioning of offspring

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News